nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—FGF1—nerve—multiple sclerosis	0.0243	0.119	CbGeAlD
Amlexanox—S100A13—Adenosine monophosphate—Cladribine—multiple sclerosis	0.0187	1	CbGdCrCtD
Amlexanox—PDE4C—brainstem—multiple sclerosis	0.0127	0.0618	CbGeAlD
Amlexanox—FGF1—brainstem—multiple sclerosis	0.0105	0.0509	CbGeAlD
Amlexanox—FGF1—retina—multiple sclerosis	0.0101	0.0491	CbGeAlD
Amlexanox—S100A13—nervous system—multiple sclerosis	0.00889	0.0433	CbGeAlD
Amlexanox—S100A13—central nervous system—multiple sclerosis	0.00856	0.0417	CbGeAlD
Amlexanox—S100A13—cerebellum—multiple sclerosis	0.00837	0.0408	CbGeAlD
Amlexanox—PDE4C—midbrain—multiple sclerosis	0.00809	0.0394	CbGeAlD
Amlexanox—FGF1—medulla oblongata—multiple sclerosis	0.00729	0.0355	CbGeAlD
Amlexanox—S100A13—brain—multiple sclerosis	0.0068	0.0331	CbGeAlD
Amlexanox—S100A12—brain—multiple sclerosis	0.00671	0.0327	CbGeAlD
Amlexanox—FGF1—midbrain—multiple sclerosis	0.00666	0.0324	CbGeAlD
Amlexanox—PDE4C—nervous system—multiple sclerosis	0.00665	0.0324	CbGeAlD
Amlexanox—FGF1—spinal cord—multiple sclerosis	0.0065	0.0316	CbGeAlD
Amlexanox—PDE4C—central nervous system—multiple sclerosis	0.0064	0.0312	CbGeAlD
Amlexanox—PDE4D—cerebellum—multiple sclerosis	0.00551	0.0268	CbGeAlD
Amlexanox—FGF1—nervous system—multiple sclerosis	0.00548	0.0267	CbGeAlD
Amlexanox—FGF1—central nervous system—multiple sclerosis	0.00527	0.0257	CbGeAlD
Amlexanox—FGF1—cerebellum—multiple sclerosis	0.00515	0.0251	CbGeAlD
Amlexanox—PDE4C—brain—multiple sclerosis	0.00508	0.0248	CbGeAlD
Amlexanox—PDE4A—cerebellum—multiple sclerosis	0.00488	0.0237	CbGeAlD
Amlexanox—PDE4D—brain—multiple sclerosis	0.00448	0.0218	CbGeAlD
Amlexanox—FGF1—brain—multiple sclerosis	0.00419	0.0204	CbGeAlD
Amlexanox—PDE4B—medulla oblongata—multiple sclerosis	0.00411	0.02	CbGeAlD
Amlexanox—PDE4A—brain—multiple sclerosis	0.00396	0.0193	CbGeAlD
Amlexanox—PDE4B—midbrain—multiple sclerosis	0.00376	0.0183	CbGeAlD
Amlexanox—PDE4B—spinal cord—multiple sclerosis	0.00367	0.0179	CbGeAlD
Amlexanox—PDE4B—nervous system—multiple sclerosis	0.00309	0.015	CbGeAlD
Amlexanox—PDE4B—central nervous system—multiple sclerosis	0.00297	0.0145	CbGeAlD
Amlexanox—PDE4B—cerebellum—multiple sclerosis	0.00291	0.0142	CbGeAlD
Amlexanox—PDE4B—brain—multiple sclerosis	0.00236	0.0115	CbGeAlD
Amlexanox—PDE4C—Signaling Pathways—CXCR3—multiple sclerosis	0.000199	0.000257	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD40—multiple sclerosis	0.000199	0.000257	CbGpPWpGaD
Amlexanox—FGF1—Immune System—ITGA4—multiple sclerosis	0.000199	0.000257	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CD80—multiple sclerosis	0.000199	0.000256	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—CCL5—multiple sclerosis	0.000198	0.000256	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IFNB1—multiple sclerosis	0.000198	0.000255	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CD28—multiple sclerosis	0.000198	0.000255	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CTLA4—multiple sclerosis	0.000197	0.000253	CbGpPWpGaD
Amlexanox—IL3—Immune System—IFNG—multiple sclerosis	0.000196	0.000253	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CD80—multiple sclerosis	0.000195	0.000252	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CCR5—multiple sclerosis	0.000195	0.000251	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—ICAM1—multiple sclerosis	0.000195	0.000251	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CCL5—multiple sclerosis	0.000195	0.000251	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CCR2—multiple sclerosis	0.000194	0.00025	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—CCR5—multiple sclerosis	0.000193	0.000249	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IL2RA—multiple sclerosis	0.000192	0.000248	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—IL2—multiple sclerosis	0.000191	0.000246	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—IL2RA—multiple sclerosis	0.00019	0.000245	CbGpPWpGaD
Amlexanox—IL3—Immune System—CD4—multiple sclerosis	0.00019	0.000244	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CD80—multiple sclerosis	0.000187	0.000242	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCL3—multiple sclerosis	0.000187	0.000241	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—CCR5—multiple sclerosis	0.000184	0.000237	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—MAPK1—multiple sclerosis	0.000184	0.000237	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—IL6—multiple sclerosis	0.000184	0.000237	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—MAPK1—multiple sclerosis	0.000184	0.000237	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—POMC—multiple sclerosis	0.000182	0.000235	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—IL2RA—multiple sclerosis	0.000182	0.000234	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CCL5—multiple sclerosis	0.00018	0.000232	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PTGER4—multiple sclerosis	0.00018	0.000232	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CNR1—multiple sclerosis	0.000179	0.000231	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—CCR5—multiple sclerosis	0.000179	0.00023	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCL3—multiple sclerosis	0.000178	0.000229	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—APOE—multiple sclerosis	0.000178	0.000229	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PGR—multiple sclerosis	0.000177	0.000228	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000176	0.000227	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CCR5—multiple sclerosis	0.000175	0.000226	CbGpPWpGaD
Amlexanox—IL3—Immune System—IL1B—multiple sclerosis	0.000175	0.000226	CbGpPWpGaD
Amlexanox—IL3—Immune System—IL2—multiple sclerosis	0.000174	0.000225	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CXCR3—multiple sclerosis	0.000174	0.000224	CbGpPWpGaD
Amlexanox—FGF1—Immune System—VCAM1—multiple sclerosis	0.000174	0.000224	CbGpPWpGaD
Amlexanox—FGF1—Immune System—HLA-DQA1—multiple sclerosis	0.000173	0.000223	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—IL2RA—multiple sclerosis	0.000173	0.000223	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CD28—multiple sclerosis	0.000172	0.000222	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PTGER4—multiple sclerosis	0.000171	0.000221	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCR2—multiple sclerosis	0.000169	0.000218	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PGR—multiple sclerosis	0.000169	0.000217	CbGpPWpGaD
Amlexanox—S100A12—Immune System—TYK2—multiple sclerosis	0.000168	0.000216	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—POMC—multiple sclerosis	0.000165	0.000213	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CXCR3—multiple sclerosis	0.000165	0.000213	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—TYK2—multiple sclerosis	0.000165	0.000212	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCL3—multiple sclerosis	0.000164	0.000212	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CD28—multiple sclerosis	0.000164	0.000211	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CCR5—multiple sclerosis	0.000162	0.000209	CbGpPWpGaD
Amlexanox—FGF1—Immune System—HLA-DQB1—multiple sclerosis	0.000162	0.000209	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—CCL2—multiple sclerosis	0.000162	0.000209	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CXCL10—multiple sclerosis	0.000161	0.000208	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCR2—multiple sclerosis	0.000161	0.000207	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CD80—multiple sclerosis	0.000161	0.000207	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IL2RA—multiple sclerosis	0.00016	0.000206	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—POMC—multiple sclerosis	0.000159	0.000204	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PTGER4—multiple sclerosis	0.000158	0.000204	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IFNG—multiple sclerosis	0.000157	0.000203	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PGR—multiple sclerosis	0.000156	0.000201	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CNR1—multiple sclerosis	0.000156	0.000201	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD86—multiple sclerosis	0.000156	0.000201	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCL3—multiple sclerosis	0.000153	0.000198	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CXCR3—multiple sclerosis	0.000153	0.000197	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD40LG—multiple sclerosis	0.000153	0.000197	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—POMC—multiple sclerosis	0.000153	0.000197	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CD4—multiple sclerosis	0.000152	0.000196	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CD28—multiple sclerosis	0.000151	0.000195	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD8A—multiple sclerosis	0.000151	0.000195	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—POMC—multiple sclerosis	0.000151	0.000195	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CCL2—multiple sclerosis	0.000149	0.000192	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CD4—multiple sclerosis	0.000149	0.000192	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCR2—multiple sclerosis	0.000149	0.000192	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CNR1—multiple sclerosis	0.000148	0.000191	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PTGER4—multiple sclerosis	0.000148	0.00019	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—TYK2—multiple sclerosis	0.000147	0.000189	CbGpPWpGaD
Amlexanox—IL3—Immune System—STAT3—multiple sclerosis	0.000147	0.000189	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—MAPK1—multiple sclerosis	0.000146	0.000188	CbGpPWpGaD
Amlexanox—FGF1—Immune System—HLA-B—multiple sclerosis	0.000145	0.000187	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PGR—multiple sclerosis	0.000145	0.000187	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—POMC—multiple sclerosis	0.000144	0.000186	CbGpPWpGaD
Amlexanox—FGF1—Disease—CD86—multiple sclerosis	0.000144	0.000185	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CD4—multiple sclerosis	0.000143	0.000184	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CXCR3—multiple sclerosis	0.000143	0.000184	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—IL6—multiple sclerosis	0.000141	0.000182	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CD28—multiple sclerosis	0.000141	0.000182	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—IL6—multiple sclerosis	0.000141	0.000182	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CD86—multiple sclerosis	0.000141	0.000182	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—CCL2—multiple sclerosis	0.000141	0.000182	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CXCL10—multiple sclerosis	0.00014	0.000181	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL1B—multiple sclerosis	0.00014	0.000181	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL2—multiple sclerosis	0.00014	0.00018	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—POMC—multiple sclerosis	0.00014	0.00018	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CCL5—multiple sclerosis	0.000139	0.000179	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCR2—multiple sclerosis	0.000139	0.000179	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CNR1—multiple sclerosis	0.000137	0.000177	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—POMC—multiple sclerosis	0.000137	0.000177	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL2RA—multiple sclerosis	0.000136	0.000176	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TYK2—multiple sclerosis	0.000136	0.000175	CbGpPWpGaD
Amlexanox—FGF1—Immune System—HLA-A—multiple sclerosis	0.000135	0.000174	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—IL2—multiple sclerosis	0.000135	0.000174	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CCL2—multiple sclerosis	0.000134	0.000173	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CXCL10—multiple sclerosis	0.000134	0.000172	CbGpPWpGaD
Amlexanox—IL3—Immune System—MAPK1—multiple sclerosis	0.000133	0.000172	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—SPP1—multiple sclerosis	0.000129	0.000166	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CNR1—multiple sclerosis	0.000128	0.000165	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—TYK2—multiple sclerosis	0.000128	0.000165	CbGpPWpGaD
Amlexanox—FGF1—Disease—CCR5—multiple sclerosis	0.000128	0.000164	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—POMC—multiple sclerosis	0.000127	0.000163	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CCR5—multiple sclerosis	0.000125	0.000161	CbGpPWpGaD
Amlexanox—FGF1—Disease—HLA-A—multiple sclerosis	0.000124	0.00016	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CCL2—multiple sclerosis	0.000124	0.00016	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CXCL10—multiple sclerosis	0.000124	0.000159	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL2RA—multiple sclerosis	0.000123	0.000159	CbGpPWpGaD
Amlexanox—FGF1—Immune System—TLR4—multiple sclerosis	0.000123	0.000159	CbGpPWpGaD
Amlexanox—FGF1—Immune System—HLA-DRB1—multiple sclerosis	0.000123	0.000159	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CD86—multiple sclerosis	0.000123	0.000158	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—IL2—multiple sclerosis	0.000122	0.000158	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—TYK2—multiple sclerosis	0.000122	0.000157	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCL5—multiple sclerosis	0.000121	0.000156	CbGpPWpGaD
Amlexanox—FGF1—Immune System—ICAM1—multiple sclerosis	0.000118	0.000152	CbGpPWpGaD
Amlexanox—S100A12—Immune System—STAT3—multiple sclerosis	0.000118	0.000152	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—IL2—multiple sclerosis	0.000117	0.000151	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CD86—multiple sclerosis	0.000117	0.000151	CbGpPWpGaD
Amlexanox—FGF1—Disease—APOE—multiple sclerosis	0.000116	0.00015	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CXCL10—multiple sclerosis	0.000115	0.000149	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCL5—multiple sclerosis	0.000115	0.000148	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—APOE—multiple sclerosis	0.000114	0.000147	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD80—multiple sclerosis	0.000114	0.000147	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IL2—multiple sclerosis	0.000113	0.000145	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—TYK2—multiple sclerosis	0.000113	0.000145	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—IL6—multiple sclerosis	0.000112	0.000145	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—SPP1—multiple sclerosis	0.000112	0.000144	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—IL2—multiple sclerosis	0.000112	0.000144	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCR5—multiple sclerosis	0.000109	0.00014	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CD86—multiple sclerosis	0.000108	0.000139	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL2RA—multiple sclerosis	0.000107	0.000138	CbGpPWpGaD
Amlexanox—S100A12—Immune System—MAPK1—multiple sclerosis	0.000107	0.000138	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MMP9—multiple sclerosis	0.000107	0.000138	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SPP1—multiple sclerosis	0.000106	0.000137	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—IL2—multiple sclerosis	0.000106	0.000137	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCL5—multiple sclerosis	0.000106	0.000137	CbGpPWpGaD
Amlexanox—FGF1—Disease—CD80—multiple sclerosis	0.000105	0.000135	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—MAPK1—multiple sclerosis	0.000105	0.000135	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCR5—multiple sclerosis	0.000104	0.000134	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—IL2—multiple sclerosis	0.000103	0.000133	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CD80—multiple sclerosis	0.000103	0.000133	CbGpPWpGaD
Amlexanox—IL3—Immune System—IL6—multiple sclerosis	0.000103	0.000132	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL2RA—multiple sclerosis	0.000102	0.000132	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—IL2—multiple sclerosis	0.000101	0.000131	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CD86—multiple sclerosis	0.000101	0.00013	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCL5—multiple sclerosis	9.92e-05	0.000128	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—APOE—multiple sclerosis	9.9e-05	0.000128	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SPP1—multiple sclerosis	9.85e-05	0.000127	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—POMC—multiple sclerosis	9.77e-05	0.000126	CbGpPWpGaD
Amlexanox—FGF1—Immune System—TYK2—multiple sclerosis	9.6e-05	0.000124	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCR5—multiple sclerosis	9.59e-05	0.000124	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CCL2—multiple sclerosis	9.56e-05	0.000123	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—STAT3—multiple sclerosis	9.49e-05	0.000122	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL2RA—multiple sclerosis	9.45e-05	0.000122	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—APOE—multiple sclerosis	9.43e-05	0.000121	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IL2—multiple sclerosis	9.38e-05	0.000121	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—MAPK1—multiple sclerosis	9.35e-05	0.000121	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SPP1—multiple sclerosis	9.19e-05	0.000118	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IFNG—multiple sclerosis	8.99e-05	0.000116	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CD80—multiple sclerosis	8.95e-05	0.000115	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCR5—multiple sclerosis	8.94e-05	0.000115	CbGpPWpGaD
Amlexanox—FGF1—Disease—TYK2—multiple sclerosis	8.86e-05	0.000114	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MYC—multiple sclerosis	8.82e-05	0.000114	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL2RA—multiple sclerosis	8.81e-05	0.000114	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TGFB1—multiple sclerosis	8.79e-05	0.000113	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—APOE—multiple sclerosis	8.72e-05	0.000112	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TYK2—multiple sclerosis	8.68e-05	0.000112	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD4—multiple sclerosis	8.68e-05	0.000112	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MAPK1—multiple sclerosis	8.63e-05	0.000111	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CD80—multiple sclerosis	8.52e-05	0.00011	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—POMC—multiple sclerosis	8.51e-05	0.00011	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCL2—multiple sclerosis	8.32e-05	0.000107	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL6—multiple sclerosis	8.22e-05	0.000106	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—MAPK1—multiple sclerosis	8.14e-05	0.000105	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—APOE—multiple sclerosis	8.13e-05	0.000105	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—POMC—multiple sclerosis	8.1e-05	0.000104	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—IL6—multiple sclerosis	8.06e-05	0.000104	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL1B—multiple sclerosis	8.02e-05	0.000103	CbGpPWpGaD
Amlexanox—FGF1—Disease—CD4—multiple sclerosis	8.02e-05	0.000103	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL2—multiple sclerosis	7.99e-05	0.000103	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCL2—multiple sclerosis	7.92e-05	0.000102	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CD80—multiple sclerosis	7.88e-05	0.000102	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—MAPK1—multiple sclerosis	7.75e-05	9.99e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TYK2—multiple sclerosis	7.56e-05	9.74e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—POMC—multiple sclerosis	7.49e-05	9.65e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CD80—multiple sclerosis	7.35e-05	9.47e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCL2—multiple sclerosis	7.33e-05	9.45e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL2—multiple sclerosis	7.22e-05	9.31e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TYK2—multiple sclerosis	7.19e-05	9.27e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—IL6—multiple sclerosis	7.19e-05	9.26e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—MAPK1—multiple sclerosis	7.17e-05	9.24e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—POMC—multiple sclerosis	6.99e-05	9e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MMP9—multiple sclerosis	6.84e-05	8.81e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCL2—multiple sclerosis	6.83e-05	8.81e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—STAT3—multiple sclerosis	6.72e-05	8.66e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TYK2—multiple sclerosis	6.66e-05	8.58e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IL6—multiple sclerosis	6.63e-05	8.54e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL2—multiple sclerosis	6.29e-05	8.1e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—IL6—multiple sclerosis	6.26e-05	8.06e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TYK2—multiple sclerosis	6.21e-05	8e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—STAT3—multiple sclerosis	6.21e-05	8e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—MAPK1—multiple sclerosis	6.11e-05	7.87e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—STAT3—multiple sclerosis	6.08e-05	7.83e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL2—multiple sclerosis	5.99e-05	7.71e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—IL6—multiple sclerosis	5.96e-05	7.68e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MMP9—multiple sclerosis	5.95e-05	7.67e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—MYC—multiple sclerosis	5.77e-05	7.43e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—TGFB1—multiple sclerosis	5.75e-05	7.41e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MMP9—multiple sclerosis	5.67e-05	7.3e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MYC—multiple sclerosis	5.65e-05	7.28e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—MAPK1—multiple sclerosis	5.64e-05	7.27e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TGFB1—multiple sclerosis	5.63e-05	7.26e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL2—multiple sclerosis	5.54e-05	7.14e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MAPK1—multiple sclerosis	5.53e-05	7.12e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IL6—multiple sclerosis	5.51e-05	7.1e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—STAT3—multiple sclerosis	5.29e-05	6.82e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MMP9—multiple sclerosis	5.24e-05	6.76e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL2—multiple sclerosis	5.16e-05	6.66e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—STAT3—multiple sclerosis	5.04e-05	6.49e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MYC—multiple sclerosis	4.92e-05	6.34e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TGFB1—multiple sclerosis	4.91e-05	6.32e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MMP9—multiple sclerosis	4.89e-05	6.3e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MAPK1—multiple sclerosis	4.81e-05	6.2e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL6—multiple sclerosis	4.69e-05	6.05e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MYC—multiple sclerosis	4.68e-05	6.03e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TGFB1—multiple sclerosis	4.67e-05	6.02e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—STAT3—multiple sclerosis	4.66e-05	6.01e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MAPK1—multiple sclerosis	4.58e-05	5.9e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—STAT3—multiple sclerosis	4.35e-05	5.6e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—IL6—multiple sclerosis	4.33e-05	5.59e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MYC—multiple sclerosis	4.33e-05	5.58e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TGFB1—multiple sclerosis	4.32e-05	5.57e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL6—multiple sclerosis	4.25e-05	5.47e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MAPK1—multiple sclerosis	4.24e-05	5.46e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MYC—multiple sclerosis	4.04e-05	5.2e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TGFB1—multiple sclerosis	4.03e-05	5.19e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MAPK1—multiple sclerosis	3.95e-05	5.09e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL6—multiple sclerosis	3.7e-05	4.76e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL6—multiple sclerosis	3.52e-05	4.53e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL6—multiple sclerosis	3.26e-05	4.2e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL6—multiple sclerosis	3.04e-05	3.91e-05	CbGpPWpGaD
